Detalhe da pesquisa
1.
The IPTA Nashville Consensus Conference on Post-Transplant lymphoproliferative disorders after solid organ transplantation in children: III - Consensus guidelines for Epstein-Barr virus load and other biomarker monitoring.
Pediatr Transplant
; 28(1): e14471, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37294621
2.
The IPTA Nashville consensus conference on Post-Transplant lymphoproliferative disorders after solid organ transplantation in children: II-consensus guidelines for prevention.
Pediatr Transplant
; : e14350, 2022 Nov 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36369745
3.
Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry.
Ann Hematol
; 100(8): 2043-2050, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-33973053
4.
European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery.
Int J Gynecol Cancer
; 31(9): 1199-1206, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34407962
5.
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Lancet
; 394(10216): 2271-2281, 2019 12 21.
Artigo
Inglês
| MEDLINE | ID: mdl-31868632
6.
Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients.
Haematologica
; 108(10): 2814-2819, 2023 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36891749
7.
Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study.
Blood
; 125(7): 1091-7, 2015 Feb 12.
Artigo
Inglês
| MEDLINE | ID: mdl-25525118
8.
Peri-operative ovarian cancer guidelines: major intra-operative and post-operative bleeding and thromboembolic events.
Int J Gynecol Cancer
; 32(12): 1621-1622, 2022 12 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36191955
9.
Impact of high risk thrombophilia status on recurrence among children and adults with VTE: An observational multicenter cohort study.
Blood Cells Mol Dis
; 62: 24-31, 2016 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27838551
10.
Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.).
Ann Hematol
; 93(12): 1953-63, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25307456
11.
The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma-a randomized, open-label phase III trial of the European mantle cell lymphoma network.
Leukemia
; 2024 Apr 27.
Artigo
Inglês
| MEDLINE | ID: mdl-38678093
12.
Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
Lancet Oncol
; 13(2): 196-206, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-22173060
13.
Expert Consensus on the Characteristics of Patients with Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi Study.
Adv Ther
; 40(3): 1267-1281, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36681739
14.
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors.
J Clin Invest
; 133(12)2023 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37159273
15.
Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study.
Hemasphere
; 7(7): e904, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37427146
16.
Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
Cancer
; 118(19): 4715-24, 2012 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-22392525
17.
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial.
Leukemia
; 36(10): 2468-2478, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35974101
18.
Host microRNAs are decreased in pediatric solid-organ transplant recipients during EBV+ Post-transplant Lymphoproliferative Disorder.
Front Immunol
; 13: 994552, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36304469
19.
Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases.
Haematologica
; 96(7): 1067-71, 2011 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-21719885
20.
IL-6 and IL-10 in post-transplant lymphoproliferative disorders development and maintenance: a longitudinal study of cytokine plasma levels and T-cell subsets in 38 patients undergoing treatment.
Transpl Int
; 24(9): 892-903, 2011 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-21668529